Sign Up to like & get
recommendations!
1
Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.9032
Abstract: 9032Background: The EGFR-T790M somatic mutation is the most common mechanism of resistance to Tyrosine Kinase Inhibitors (TKI) in NSCLC. However patients with advanced disease are not always amenab...
read more here.
Keywords:
t790m mutations;
egfr t790m;
mutations exhaled;
detection egfr ... See more keywords